scholarly article | Q13442814 |
P2093 | author name string | T Li | |
P Lin | |||
R MacLean | |||
J C Cole | |||
G V Wallenstein | |||
P433 | issue | 7 | |
P921 | main subject | rheumatoid arthritis | Q187255 |
placebo | Q269829 | ||
P304 | page(s) | 1044-1050 | |
P577 | publication date | 2008-05-17 | |
P1433 | published in | Rheumatology | Q7320492 |
P1476 | title | Treatment impact on estimated medical expenditure and job loss likelihood in rheumatoid arthritis: re-examining quality of life outcomes from a randomized placebo-controlled clinical trial with abatacept | |
P478 | volume | 47 |
Q24240131 | Abatacept for rheumatoid arthritis |
Q36032715 | Decision tool to improve the quality of care in rheumatoid arthritis |
Q38689012 | Estimated medical expenditure and risk of job loss among rheumatoid arthritis patients undergoing tofacitinib treatment: post hoc analyses of two randomized clinical trials |
Q36931485 | Investigating the value of abatacept in the treatment of rheumatoid arthritis: a systematic review of cost-effectiveness studies |
Q37682875 | Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity |
Q37633537 | Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists |
Search more.